Homeopathic teething tablets and gels may pose a health risk to infants and children, the US Food and Drug Administration (FDA) has warned.
Consumers should stop using these products and dispose of any in their possession, FDA recommended on Friday.
Homeopathic teething tablets and gels are distributed by CVS, Hyland's, and possibly others, and are sold in retail stores and online, the US drug regulator said in a statement.
Following the FDA's warning, CVS announced a voluntary withdrawal of all brands of homeopathic teething products sold in its retail stores and online at CVS.com.
"Consumers should seek medical care immediately if their child experiences seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating, or agitation after using homeopathic teething tablets or gels," FDA said.
"Teething can be managed without prescription or over-the-counter remedies," said Janet Woodcock, Director of the FDA's Center for Drug Evaluation and Research.
"We recommend parents and caregivers not give homeopathic teething tablets and gels to children and seek advice from their health care professional for safe alternatives," Woodcock noted.
The FDA is analysing adverse events reported to the agency regarding homeopathic teething tablets and gels, including seizures in infants and children who were given these products, since a 2010 safety alert about homeopathic teething tablets.
The FDA is currently investigating this issue, including testing product samples.
--IANS
gb/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
